Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Kadmon Holdings, Inc.

NYSE: KDMNHealthcare / Biotechnology / USA
2.41-0.0400-1.63%Vol 245 1891Y Perf -46.92%
Jan 18th, 2019 16:02
BID2.41 ASK2.42
Open2.46 Previous Close2.45
Pre-Market- After-Trading2.41
 - -%  - -%
Target Price
13.63 
Analyst Rating
Moderate Buy 1.67
Potencial %
465.56 
Finscreener Ranking
★★★★     54.77
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★     51.67
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★     46.26
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)273 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
13.32 
Earnings Date
5th Mar 2019

Today's Price Range

2.362.47

 

52wk Range

1.885.86

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
13.68%
3 Months
-7.66%
6 Months
-29.74%
1 Year
-46.92%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
KDMN2.41-0.0400-1.63
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
6.50
Current Ratio
6.60
Long Term Debt to Total Capital
0.18
Total Debt to Equity
0.32
Interest Coverage
-5.20
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
68.60
EBIT Margin
-1 019.10
EBITDA Margin
-960.50
Pre-tax Profit Margin
-516.50
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
2.20
PB Ratio
3.20
PS Ratios
237.15
Price to Cash Flow
-
Price to Free Cash Flow
-5.20
Cash Flow Per Share
-0.80
Price to Tangible Book
3.34
Book Value per Share
0.76
Enterprise Value (in ths.)
231 790
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-126.90
Return on Assets (5Y Avg)
-
ROA last 12 Months
-24.53
Return on Capital (5Y Avg)
-
ROC last 12 Months
-53.89
Return on invested Capital Q
-11.72
Return on invested Capital Y
-
Assets Turnover
0.00
Receivables Turnover
0.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
1 164
Revenue per Share
0.01
Revenue Growth 3 Years
-59.64
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.22-0.1340.91
Q02 2018-0.26-0.2119.23
Q01 2018-0.25-0.27-8.00
Q04 2017-0.34-0.2429.41
Q03 2017-0.41-0.42-2.44
Q02 2017-0.55-0.4420.00
Q01 2017-0.50-0.3922.00
Q04 2016-0.52-0.503.85
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.1726.09Positive
12/2018 FY-0.78-271.43Negative
3/2019 QR-0.204.76Positive
12/2019 FY-0.5343.62Positive
Next Report Date5th Mar 2019
Estimated EPS Next Report-0.17
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume245 189
Shares Outstanding (in ths.)113 131
Trades Count730
Dollar Volume504 200
Avg. Volume1 669 606
Avg. Weekly Volume420 994
Avg. Monthly Volume1 328 009
Avg. Quarterly Volume914 103

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

27%73%

Bearish Bullish

31%69%

Bearish Bullish

47%53%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Strong Buy
1.50
Strong Buy
1.50

There are no comments yet.

News